Verdence Capital Advisors’s Globus Medical GMED Stock Holding History

Verdence Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Buy	3,409 +117	+4%	+$9.95K	0.01%	574
2026 Q1	$284K	Sell	3,292 -8,167	-71%	-$733K	0.02%	541
2025 Q4	$1M	Sell	11,459 -3,007	-21%	-$228K	0.06%	275
2025 Q3	$915K	Buy	14,466 +696	+5%	+$40.1K	0.05%	319
2025 Q2	$813K	Buy	13,770 +8,223	+148%	+$531K	0.06%	295
2025 Q1	$406K	Buy	5,547 +1,036	+23%	+$85.6K	0.03%	449
2024 Q4	$373K	Buy	4,511 +9	+0.2%	+$710	0.03%	427
2024 Q3	$322K	Sell	4,502 -3,648	-45%	-$258K	0.03%	497
2024 Q2	$558K	Sell	8,150 -2,003	-20%	-$120K	0.05%	332
2024 Q1	$545K	Buy	+10,153	New	+$546K	0.05%	335

Other funds holding GMED

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Verdence Capital Advisors's GMED Position: Q2 2026 in Review

Verdence Capital Advisors increased its Globus Medical (GMED) stake by 3.6% in Q2 2026, buying an estimated $9.95K and bringing the position to 3,409 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #574.

Verdence Capital Advisors first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $1M in Q4 2025. 213 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Verdence Capital Advisors held 3,409 shares of Globus Medical worth $269K as of Q2 2026.
Verdence Capital Advisors bought 117 Globus Medical shares in Q2 2026, an estimated $9.95K.
Globus Medical made up 0.01% of Verdence Capital Advisors's portfolio in Q2 2026, its #574 holding.
Verdence Capital Advisors first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
Verdence Capital Advisors's Globus Medical position peaked at $1M in Q4 2025.
213 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.